Health TrialsbyHealthPanel

Radiotherapy-induced Nausea and Vomiting (RINV)

2

Review clinical trials related to Radiotherapy-induced Nausea and Vomiting (RINV). Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Study to Compare the Bioavailability of Ondansetron Following Nasal (NS003) and IV Administration in Healthy Adults

A Study to Compare the Bioavailability of Ondansetron Following Nasal (NS003) and IV Administration in Healthy Adults

Participants needed: 12
Trial details
Phase: Phase 1Age: 18-65Biological sex: AllType: InterventionalSponsor: Nasus PharmaUpdated: Oct 9, 2026Locations: 1
Eligibility criteria

Non-smoking, male and female subjects from 18 to 65 years of age. [+8]

Known history or presence of clinically significant neurologic, hematologic, end... [+36]

Read more
Status: Recruiting

Ondansetron Orodispersible Film for Vomiting Prevention in Pediatric Radiotherapy

The goal of this study is to evaluate the antiemetic efficacy and drug safety of ondansetron orodispersible film in pediatric patients with malignant tumors who received moderate emetic risk radiation induced vomiting, and to formulate reasonable and effective clinical medication regimen for preventing vomiting caused by moderate emetic risk radiation in children with malignant tumor.

Participants needed: 60
Trial details
Phase: Phase 4Age: 1-14Biological sex: AllType: InterventionalSponsor: Chongqing University Cancer HospitalUpdated: Oct 20, 2025Locations: 1
Eligibility criteria

Children with malignant tumors diagnosed by histopathology [+9]

The nausea and vomiting caused by the surgery have not fully recovered if the su... [+9]

Read more